retatrutide trial weight loss results The next big shift in obesity care may not be surgery — it may be a weekly shot. Retatrutide, an investigational triple-action medicine, showed 28.3% average body-weight over 80 weeks in Retatrutide Shines in Obesity Trial

The PlexusDx Precision Peptide Genetic Test ($99 add-on after your first month) reveals 150+ genetic insights to guide personalization

According to FDA guidance, compounded medications are prepared by licensed pharmacies based on individual prescriptions using FDA-approved active ingredients, but the finished compounded products themselves are not FDA-approved and have not undergone the same regulatory review for safety, effectiveness, and quality that approved drugs receive

This can lead to ineffective benefits in both weight and blood sugar control

Remember, the best medication is the one that works effectively for your body while fitting your lifestyle and budget

Getting this synthesis right, consistently, at scale, requires sophisticated manufacturing capability